View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Macerich Schedules Third Quarter 2024 Earnings Release and Conference ...

Macerich Schedules Third Quarter 2024 Earnings Release and Conference Call SANTA MONICA, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules Third Quarter 2024 Earnings Release and Conference Call WHEN: Earnings Results will be released before market open on Wednesday, November 6, 2024. Management will hold a conference call at 10:00 am Pacific Time (1:00 pm Eastern Time) on that same day to discuss quarterly results. WHERE: Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-in n...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Macerich to Present at BofA Securities 2024 Global Real Estate Confere...

Macerich to Present at BofA Securities 2024 Global Real Estate Conference SANTA MONICA, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) today announced that Jack Hsieh, President and Chief Executive Officer, Scott Kingsmore, Senior Executive Vice President and Chief Financial Officer, and Doug Healey, Senior Executive Vice President Leasing will present to/speak with investors at BofA Securities 2024 Global Real Estate Conference in New York, NY September 10-11, 2024. Macerich will present at 1:30 p.m. Eastern on Tuesday, September 10, 2024. The live audio...

 PRESS RELEASE

Macerich Releases 2023 Corporate Responsibility Report

Macerich Releases 2023 Corporate Responsibility Report Report marks 15 years of industry-leading sustainability strategy by leading retail real estate company SANTA MONICA, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation's leading owners, operators and developers of major retail properties in top markets, today released its 2023 Corporate Responsibility Report, with data for the period ending December 31, 2023. This year’s “Together for Tomorrow” theme emphasizes the company’s environmental sustainability, social and governance efforts in service of its...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Downgrading Outlook to Neutral; Upgrading Real Estate and Consumer Staples We are downgrading our long-term outlook to neutral (had been bullish since early-November 2023) due to rapidly deteriorating market dynamics; we still believe the S&P 500 is going through a 1- to 4-month consolidation phase, but odds have increased that this consolidation phase could be a topping pattern. The S&P 500 is initially holding at our expected pullback zone of 5100-5191 that we discussed last week (7/30/24 Com...

Ritika Das ... (+3)
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
 PRESS RELEASE

Revolution Medicines Reports Second Quarter 2024 Financial Results and...

Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its financial results for the quarter ended June 30, 2024, and provided an update on corporate progress. The company continues making progress on its 2024 development priorities: Advancing its RAS(ON) mu...

 PRESS RELEASE

Revolution Medicines to Report Financial Results for Second Quarter 20...

Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024 REDWOOD CITY, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the second quarter 2024 on Wednesday, August 7, 2024, after market close. At 4:30 p.m. Eastern Time that day (1:30 p.m. Pacific Time), Revolution Medicines’ senior management team will host a webcast to discuss the financial...

 PRESS RELEASE

Macerich Reports Second Quarter 2024 Results

Macerich Reports Second Quarter 2024 Results SANTA MONICA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has released its Second Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at . As previously announced, management will hold a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) today, Wednesday, July 31, 2024, to discuss quarterly results. Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial...

 PRESS RELEASE

Macerich Declares the Quarterly Dividend on Its Common Shares

Macerich Declares the Quarterly Dividend on Its Common Shares SANTA MONICA, Calif., July 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $.17 per share of common stock. The dividend is payable on September 9, 2024, to stockholders of record at the close of business on August 19, 2024. About Macerich Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractiv...

 PRESS RELEASE

Macerich Announces the Return of Diana M. Laing to Board of Directors

Macerich Announces the Return of Diana M. Laing to Board of Directors Laing Previously Served on Macerich Board from 2003-2022; Was Board Member at Spirit Realty Capital During Macerich President and CEO Jackson Hsieh’s Successful Tenure at the Company SANTA MONICA, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced the appointment of Diana M. Laing to its Board of Directors. Ms. Laing previously served on Macerich’s Board from 2003 through 2022. With the ad...

Wedbush Research
  • Wedbush Research
TPX TEMPUR SEALY INTERNATIONAL INC
W WAYFAIR INC.
2454 MEDIATEK INC.
VMW VMWARE INC. CLASS A
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
WAL WESTERN ALLIANCE BANCORP
TRNO TERRENO REALTY CORPORATION
STAG STAG INDUSTRIAL INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SAGE SAGE THERAPEUTICS INC.
RWT REDWOOD TRUST INC.
REXR REXFORD INDUSTRIAL REALTY INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FR FIRST INDUSTRIAL REALTY TRUST INC.
ETSY ETSY INC.
EGP EASTGROUP PROPERTIES INC.
CTMX CYTOMX THERAPEUTICS INC.
CFG CITIZENS FINANCIAL GROUP INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
HPE HEWLETT PACKARD ENTERPRISE CO.
FND FLOOR & DECOR HOLDINGS INC. CLASS A
PLYM PLYMOUTH INDUSTRIAL REIT INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
SNBR SLEEP NUMBER CORPORATION
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
AVGO BROADCOM INC.
PRPL PURPLE INNOVATION
KNSA KINIKSA PHARMACEUTICALS
COOP MR. COOPER GROUP INC.
CHWY CHEWY INC. CLASS A
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
SWTX SPRINGWORKS THERAPEUTICS
PFSI PENNYMAC FINANCIAL SERVICES INC.
RVMD REVOLUTION MEDICINES
BDTX BLACK DIAMOND THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
PRAX PRAXIS PRECISION MEDICINES
COGT COGENT BIOSCIENCES INC
RKT ROCKET COMPANIES
VRDN VIRIDIAN THERAPEUTICS INC
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
GHLD GUILD HOLDINGS
FHTX FOGHORN THERAPEUTICS
LBPH LONGBOARD PHARMACEUTICALS
MRVL MARVELL TECHNOLOGY INC
STX SEAGATE TECHNOLOGY HLDGS PLC
IKNA IKENA ONCOLOGY INC
UWMC UWM HLDGS CORP
JANX JANUX THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DBD DIEBOLD NIXDORF INCORPORATED
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch